American Standard throws in towel and sells back DiaSorin
This article was originally published in Clinica
After a brief foray into the medical diagnostics business, American Standard has admitted defeat and has sold its DiaSorin business. It goes to a management buyout backed by an investment banks and the Italian SNIA conglomerate - the same company that sold the diagnostics business to American for $220 million in cash, three years ago (see Clinica No 742, p 1).
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.